Just one third of patients with depression respond to their initial medication trial while a similar number have no adequate clinical response after being treated with several different medications, according to a new STAR*D study conducted by researchers at National Institute of Mental Health. A new study published in iBiological Psychiatry/i now shares progress in identifying genomic predictors of antidepressant response. Many previous studies ...
via Medindia Health News More READ
No comments:
Post a Comment